JP2022516400A5 - - Google Patents

Info

Publication number
JP2022516400A5
JP2022516400A5 JP2021524174A JP2021524174A JP2022516400A5 JP 2022516400 A5 JP2022516400 A5 JP 2022516400A5 JP 2021524174 A JP2021524174 A JP 2021524174A JP 2021524174 A JP2021524174 A JP 2021524174A JP 2022516400 A5 JP2022516400 A5 JP 2022516400A5
Authority
JP
Japan
Prior art keywords
fewer
seq
peptide
diabetes
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021524174A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022516400A (ja
JP7553115B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2019/080563 external-priority patent/WO2020094797A1/en
Publication of JP2022516400A publication Critical patent/JP2022516400A/ja
Publication of JP2022516400A5 publication Critical patent/JP2022516400A5/ja
Application granted granted Critical
Publication of JP7553115B2 publication Critical patent/JP7553115B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021524174A 2018-11-07 2019-11-07 糖尿病治療のためのペプチド断片 Active JP7553115B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP18204862 2018-11-07
EP18204862.9 2018-11-07
PCT/EP2019/080563 WO2020094797A1 (en) 2018-11-07 2019-11-07 Peptide fragments for treatment of diabetes

Publications (3)

Publication Number Publication Date
JP2022516400A JP2022516400A (ja) 2022-02-28
JP2022516400A5 true JP2022516400A5 (https=) 2022-11-11
JP7553115B2 JP7553115B2 (ja) 2024-09-18

Family

ID=64183928

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021524174A Active JP7553115B2 (ja) 2018-11-07 2019-11-07 糖尿病治療のためのペプチド断片

Country Status (13)

Country Link
US (2) US20220002343A1 (https=)
EP (1) EP3876970A1 (https=)
JP (1) JP7553115B2 (https=)
KR (1) KR20210088583A (https=)
CN (1) CN113164548A (https=)
AU (1) AU2019374981A1 (https=)
BR (1) BR112021008888A2 (https=)
CA (1) CA3116612A1 (https=)
IL (1) IL282519A (https=)
MX (1) MX2021005386A (https=)
SG (1) SG11202104276YA (https=)
WO (1) WO2020094797A1 (https=)
ZA (1) ZA202102572B (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023218095A1 (en) * 2022-05-13 2023-11-16 Coegin Pharma Ab Agents for stimulating tissue regeneration
JP2025516717A (ja) * 2022-05-13 2025-05-30 コーギン ファーマ エービー 血管新生を誘発する薬剤

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10505750A (ja) * 1994-09-16 1998-06-09 ザ スクリップス リサーチ インスティテュート 粘着および軸索の成長を刺激するサイトタクチン誘導体並びにその製造および使用方法
WO2004015390A2 (en) 2002-08-09 2004-02-19 Applera Corporation Lung cancer target proteins and use thereof
CN100503637C (zh) * 2004-04-14 2009-06-24 浙江贝达药业有限公司 胰高血糖素样肽类似物、其组合物及其使用方法
US9044438B2 (en) * 2005-06-17 2015-06-02 Yitzchak Hillman Disease treatment via antimicrobial peptides or their inhibitors
EP2114422A1 (en) * 2007-03-02 2009-11-11 National University of Ireland, Galway Osteopontin for the prediction and treatment of cardiovascular diseases
GB2493540A (en) * 2011-08-10 2013-02-13 Follicum Ab Agents for stimulating hair growth in mammals
GB201406989D0 (en) * 2014-04-17 2014-06-04 Follicum Ab Novel treatments
CA3061935A1 (en) * 2017-05-04 2018-11-08 Follicum Ab Peptides for treatment of diabetes

Similar Documents

Publication Publication Date Title
US20190085043A1 (en) Fusion proteins for treating a metabolic syndrome
RU2606840C2 (ru) Композиция для лечения диабета, содержащая конъюгат инсулина длительного действия и конъюгат инсулинотропного пептида длительного действия
CN106459170B (zh) 衍生自毒蜥外泌肽-4的glp-1/胰高血糖素受体双重激动剂
ES2674581T3 (es) Análogo de exendina-4 pegilado con polietilenglicol o derivado del mismo, método de preparación del mismo y composición farmacéutica para evitar o tratar diabetes, que contiene el mismo como principio activo
US9175037B2 (en) Neuromedin U derivative
US20220016215A1 (en) Gip receptor agonist peptide compounds and uses thereof
JP2010031018A5 (https=)
US20100286035A1 (en) Neuromedin u derivative
KR102163936B1 (ko) 장기-활성 싱글-체인 인슐린 유사체
WO2012050227A1 (en) Peptide derivative
JP2014524908A5 (https=)
JP2020518556A5 (https=)
WO2010013012A4 (en) Hypothermia inducing polypeptides and uses thereof
JP2023528207A5 (https=)
JP2008500373A5 (https=)
JP2022516400A5 (https=)
RU2007110981A (ru) Урокортин iii и его использование
JP2026009897A (ja) Ｇｉｐ受容体アゴニストペプチド化合物及びその使用
EP3838925A1 (en) Long-acting recombinant glp1-fc-cd47 protein, preparation method and use thereof
JP2024500284A (ja) 芳香族ホウ素含有化合物及びインスリン類似体
US20130012455A1 (en) Use of ARC for inhibiting cell death during liver failure
US20200282021A1 (en) Glp-1 fusion proteins and uses thereof
TW202409070A (zh) 芳族含硼化合物及相關胰島素類似物
CN105985425B (zh) 一种聚乙二醇修饰的exendin类似物及其制备方法和应用
SA515360713B1 (ar) مـشـتـق ببـتـيد انتحـائي للأنسـولين ذي شـحنة مـعـدلة عـنـد N-Terminal